OncoSummit 2026
International Virtual Conference on Cancer Research & Therapy
Theme: Advancing Innovation in Cancer Research & Therapy
September 16–18, 2026 | Zoom Meeting
60+ Participants • 40+ Countries
About the Summit
OncoSummit 2026 is designed for oncologists, researchers, healthcare professionals, academic scholars, and industry experts who are actively engaged in advancing cancer diagnosis, treatment, and patient care. The conference provides a collaborative platform to exchange insights, present research findings, and explore emerging technologies shaping the future of oncology.
The program features keynote sessions, expert-led discussions, and peer-reviewed presentations across multiple scientific tracks. Participants will gain exposure to cutting-edge developments in precision medicine, immunotherapy, artificial intelligence in oncology, and global clinical trials.
By bringing together a diverse international community, OncoSummit 2026 aims to accelerate innovation, foster meaningful collaborations, and bridge the gap between research and real-world clinical application.
Quick Facts
- 30+ Global Speakers
- 8 Scientific Tracks
- 40+ Countries Represented
- Digital Certificate of Attendance
Scientific Tracks
Precision Medicine
- Genomic profiling & biomarkers
- Targeted therapies
- Personalized oncology treatments
Immunotherapy
- CAR-T cell therapy
- Immune checkpoint inhibitors
- Tumor microenvironment
AI in Oncology
- AI in cancer diagnostics
- Medical imaging & pathology
- Predictive analytics
Clinical Trials
- Phase I–III trials
- Regulatory frameworks
- Real-world evidence
Public Health & Prevention
- Cancer epidemiology
- Screening & early detection
- Prevention strategies
Featured Presenters
OncoSummit 2026 features contributions from researchers and clinicians representing leading institutions in cancer research and clinical oncology.
Dr. Regina A. Jacob
Northwell Cancer Institute, USA
Dr. Sofia Gameiro
National Cancer Institute, USA
Dr. Paul Frankel
City of Hope, USA
Call for Abstracts
OncoSummit 2026 invites researchers, clinicians, and academic professionals to submit original research, clinical studies, and evidence-based findings in the field of cancer research and therapy.
Selected abstracts will be presented at the conference and published in the official proceedings.
Submission Timeline
Early Deadline
June 30, 2026
Standard Deadline
July 30, 2026
Final Deadline
August 15, 2026
Conference Dates
September 16–18, 2026
All submissions will undergo peer review. Due to limited presentation capacity, early submission is strongly recommended.
Presentation Formats
Keynote
40 min + 5 min Q&A
Invited Speaker
25 min + 5 min Q&A
Oral Presentation
20 min + 5 min Q&A
Poster
A0, portrait format
REGISTRATION OPEN
Secure Your Place
Participation is limited. Early registration ensures lower pricing and priority inclusion in the program.
Speaker (Oral)
For accepted abstract presenters.
- Early Bird$129
- Regular$179
- Final$229
Delegate / Attendee
Full access to sessions, keynotes, and networking.
- Early Bird$149
- Regular$199
- Final$249
E-Poster Presentation
For poster session participants.
- Early Bird$99
- Regular$149
- Final$199
Student
Special discounted category.
- Early Bird$89
- Regular$139
- Final$189
Important Dates
Early bird pricing closes soon. Secure your slot before capacity fills.
Register NowScientific Program
Program Overview
- 3 Days Scientific Sessions
- Keynote & Invited Talks
- Parallel Oral Sessions
- Poster Presentations
- Networking Breaks
Day Highlights
Inauguration, Keynotes, Scientific Sessions
Advanced Sessions & Parallel Tracks
Posters, Final Sessions & Closing Ceremony
Who Should Attend
- Oncologists & Clinical Researchers
- Healthcare Professionals
- Pharma & Biotech Experts
- Academic Scientists
- Students & Early Career Researchers
Why Attend
- Learn from global experts
- Present your research
- Discover latest innovations
- Build collaborations
- Enhance professional visibility